STSS - NASDAQ

Sharps Technology, Inc.

STSS·NASDAQ

$1.84

+1.1%

HealthcareMedical - Instruments & Supplies

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$77.87M

EPS-11.1600

P/E Ratio-0.18

Earnings Date09/02/2026

stss

Cash at Beginning of Period

Last Annual Value

1.00M

3-Year CAGR

-12%

5-Year CAGR

10%

10-Year CAGR

Adjust for Inflation

Sharps Technology, Inc. Competitors Analysis of Cash at Beginning of Period

STSS · NASDAQ

Company	Cash at Beginning of Period	CAGR 3Y	CAGR 5Y	CAGR 10Y
Sharps Technology, Inc. NASDAQ:STSS	1.00M	-37.8%	-10.9%	N/A
The Joint Corp. NASDAQ:JYNT	26.00M	35.1%	4.5%	4.5%
Microbot Medical Inc. NASDAQ:MBOT	3.16M	7.9%	-30.7%	21.9%
Greenwich LifeSciences, Inc. NASDAQ:GLSI	4.09M	-32.8%	-32.2%	N/A
Hyperfine, Inc. NASDAQ:HYPR	37.67M	-31.7%	-10.1%	N/A
Crescent Biopharma, Inc. NASDAQ:CBIO	34.77M	-10.1%	-24.0%	-2.9%
Cardiff Oncology, Inc. NASDAQ:CRDF	51.47M	46.6%	-17.0%	-2.7%
KORU Medical Systems, Inc. NASDAQ:KRMD	9.58M	-18.0%	-18.9%	8.6%
Nuvectis Pharma, Inc. NASDAQ:NVCT	18.53M	-2.5%	N/A	N/A
Owlet, Inc. NYSE:OWLT	20.63M	22.5%	3.9%	N/A
Utah Medical Products, Inc. NASDAQ:UTMD	82.98M	3.4%	10.0%	13.6%

Sharps Technology, Inc. Fair Value Envelope

STSS · NASDAQ

Our analysis suggests that STSS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.84, this represents a potential HIDDEN relative to our calculated worth for Sharps Technology, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.84

Related Guides

Blog Categories

Continue your STSS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.